Amvis Holdings.Inc. (7071) AI Stock Analysis

• Market Cap: ¥51.42B
• Dividend Yield: 0.76%
• Average Volume (3M): 553.27K
• Price to Earnings (P/E): 7.4
• Beta (1Y): 0.82
• Revenue Growth: 30.50%
• EPS Growth: 3.57%
• Country: JP
• Employees: 4,046
• Sector: Healthcare
• Sector Strength: 38
• Industry: Medical - Care Facilities
• EPS (TTM): N/A
• Shares Outstanding: 98,313,600
• 10 Day Avg. Volume: 528,380
• 30 Day Avg. Volume: 553,273
• PEG Ratio: -1.09
• Price to Book (P/B): 1.41
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 0.00
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: ¥540.00
• Price Target Upside: 1.50% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 0

• Rating: 81 Outperform
• Price Target: ¥625.00 ▲(17.48%Upside)

Amvis Holdings Inc. shows a strong overall performance driven by its robust financial performance, attractive valuation, and positive technical momentum. Key risks involve managing rising debt levels and addressing cash flow inefficiencies to sustain growth.

Amvis Holdings.Inc. Business Overview & Revenue Model

Company Description

Amvis Holdings Inc. (7071) is a Japanese company primarily engaged in the healthcare sector. The company specializes in providing hospice and home care services, focusing on end-of-life care for patients with terminal illnesses. Its core services aim to enhance the quality of life for patients and support families through comprehensive care plans managed by professional medical staff.

How the Company Makes Money

Amvis Holdings Inc. generates revenue through its hospice and home care services. The company primarily earns money by offering customized care programs tailored to the needs of patients requiring end-of-life care. These services are often covered by health insurance plans, government subsidies, or out-of-pocket payments from patients and their families. Additionally, the company may form partnerships with healthcare providers and institutions to expand its service offerings and reach more clients, further driving its revenue growth. Key factors contributing to its earnings include the increasing demand for specialized healthcare services due to an aging population and the rising awareness of the benefits of hospice care.

Amvis Holdings.Inc. Financial Statement Overview

Summary

Amvis Holdings Inc. exhibits strong revenue growth and profitability margins. However, the balance sheet shows rising debt levels, and cash flow management is a concern with zero free cash flow reported in TTM. Overall, the financials are solid, but improvements in cash management are needed.

Income Statement

Amvis Holdings Inc. demonstrates robust financial performance with steady revenue growth, as indicated by a significant TTM revenue of 44.7 billion JPY compared to 31.9 billion JPY in the previous annual period, marking a growth rate of approximately 32.8%. The gross profit margin remains strong at 38.3% in TTM, reflecting effective cost management. The net profit margin is healthy at 15.6% in TTM, though there has been a slight decline from previous periods, suggesting some pressure on net income. EBIT and EBITDA margins are also solid at 22.3% and 26.5% respectively, showcasing operational efficiency.

Balance Sheet

The balance sheet of Amvis Holdings Inc. indicates a strong equity position with a debt-to-equity ratio of 0.99 in TTM, which is manageable, though it has increased compared to previous years. The company's equity ratio stands at 45.9%, reflecting a balanced capital structure. Return on equity is impressive at 20.6% in TTM, indicating effective use of shareholder funds. However, the increased total debt level may pose potential risks if not managed carefully.

Cash Flow

Cash flow analysis reveals challenges, as the company reports a zero free cash flow in TTM, indicating issues in cash generation after investments. The operating cash flow to net income ratio is unavailable due to missing data, which makes it difficult to assess cash flow efficiency. Historical data shows a negative trend in free cash flow, highlighting the need for improved cash management.

Breakdown	Sep 2024	Sep 2023	Sep 2022	Sep 2021	Sep 2020
Income Statement
Total Revenue	42.48B	31.98B	23.07B	15.33B	9.17B
Gross Profit	17.06B	13.27B	9.69B	6.30B	3.75B
EBITDA	12.76B	10.39B	7.10B	4.48B	2.17B
Net Income	7.44B	6.31B	4.28B	2.63B	1.24B
Balance Sheet
Total Assets	71.80B	55.56B	41.77B	31.92B	16.52B
Cash, Cash Equivalents and Short-Term Investments	8.87B	12.13B	11.34B	11.19B	3.33B
Total Debt	31.75B	23.05B	17.43B	12.75B	9.55B
Total Liabilities	38.59B	29.04B	21.31B	15.58B	11.27B
Stockholders Equity	33.21B	26.52B	20.46B	16.34B	5.25B
Cash Flow
Free Cash Flow	-8.52B	-3.06B	-2.73B	-2.79B	-3.78B
Operating Cash Flow	7.48B	6.80B	4.42B	2.58B	1.17B
Investing Cash Flow	-16.83B	-10.31B	-7.75B	-5.78B	-5.30B
Financing Cash Flow	6.08B	4.30B	3.49B	11.05B	7.02B

Amvis Holdings.Inc. Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 532.00
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:7071, the sentiment is Positive. The current price of 532 is above the 20-day moving average (MA) of 502.20, above the 50-day MA of 479.84, and below the 200-day MA of 752.49, indicating a neutral trend. The MACD of 13.51 indicates Negative momentum. The RSI at 60.50 is Neutral, neither overbought nor oversold. The STOCH value of 64.98 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:7071.

Amvis Holdings.Inc. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
7071	81 Outperform	¥51.42B	7.35		0.76%	30.50%	3.57%
6197	80 Outperform	¥40.74B	10.02		4.56%	1.70%	83.74%
2374	78 Outperform	¥19.43B	12.88		3.86%	4.15%	-25.67%
6062	76 Outperform	¥43.37B	10.20		2.65%	7.94%	8.41%
6099	76 Outperform	€51.87B	21.37	20.85%	1.54%	14.88%	-4.79%
9158	73 Outperform	¥34.36B	10.97		―	42.45%	20.44%
Sector *	65 Neutral	¥352.42B	10.85	-2.99%	2.46%	11.67%	-10.31%

Amvis Holdings.Inc. Corporate Events

Amvis Holdings Granted Extension for Semiannual Report Submission

Amvis Holdings, Inc. has received approval to extend the deadline for submitting its semiannual report for the fiscal year ending September 2025. The new deadline is set for August 14, 2025, allowing the company to complete necessary investigations and reviews. This extension aims to ensure accurate reporting and maintain transparency with stakeholders, despite any concerns this delay may cause.

Amvis Holdings Seeks Extension for Semiannual Report Amid Investigation

Amvis Holdings, Inc. has applied for an extension to submit its semiannual report for the fiscal year ending September 2025 due to an ongoing investigation into improper medical fee claims at its nursing facilities. The investigation, led by an independent Special Investigation Committee, is extensive and involves digital forensics, data analysis, and interviews, necessitating more time to ensure thoroughness, with the report expected by the extended deadline of August 14, 2025.

Amvis Holdings Delays Financial Results Amid Investigation

Amvis Holdings, Inc. has postponed its financial results announcement for the first half of the fiscal year ending September 30, 2025, due to an ongoing investigation into allegations of improper medical service fee claims. The delay is necessary to allow a Special Investigation Committee to conduct thorough research, including interviews and document analysis, across its 119 facilities, which may impact stakeholders’ confidence and the company’s market position.